Multicenter study of ceftolozane/tazobactam for treatment of Pseudomonas aeruginosa infections in critically ill patients-Reference-Cited by-同舟云学术

Multicenter study of ceftolozane/tazobactam for treatment of Pseudomonas aeruginosa infections in critically ill patients

Published:2021-03 Issue:3 Volume:57 Page:106270
ISSN:0924-8579
Container-title:International Journal of Antimicrobial Agents
language:en
Short-container-title:International Journal of Antimicrobial Agents

Author:

Balandin Bárbara,Ballesteros Daniel,Ruiz de Luna Rafael,López-Vergara Loreto,Pintado Vicente,Sancho-González Milagros,Soriano-Cuesta Cruz,Pérez-Pedrero Maria José,Asensio-Martín Maria José,Fernández-Simón Inamculada,Rodríguez-Serrano Diego,Silva Alberto,Chicot Marta^ORCID,Iranzo Reyes,Martínez-Sagasti Fernando,Royuela Ana

Publisher

Elsevier BV

Subject

Pharmacology (medical),Infectious Diseases,Microbiology (medical),General Medicine

Reference36 articles.

1. Rational approach in the management of Pseudomonas aeruginosa infections;Bassetti;Curr Opin Infect Dis,2018

2. Host and pathogen biomarkers for severe Pseudomonas aeruginosa infection;Juan;J Infect Dis,2017

3. A global priority list of the TOp TEn resistant microorganism (TOTEM) study at intensive care: a prioritization exercise based on multi-criteria decision analysis;Rello;Eur J Clin Microbiol Infect Dis,2019

4. How to manage Pseudomonas aeruginosa infections;Bassetti;Drugs Context,2018

5. Antibiotic selection in the treatment of acute invasive infections by Pseudomonas aeruginosa: guidelines by the Spanish Society of Chemotherapy;Mensa;Rev Esp Quimioter,2018

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Multicentre study of cefiderocol for treatment of Gram-negative bacteria infections in critically ill patients;International Journal of Antimicrobial Agents;2024-05

2. Cost-effectiveness analysis of CTZ/TAZ for the treatment of ventilated hospital-acquired bacterial pneumonia and ventilator-associated bacterial pneumonia in Japan;BMC Health Services Research;2024-03-28

3. The burden of antibiotic resistance of the main microorganisms causing infections in humans – review of the literature;Journal of Medicine and Life;2024-03

4. Effect of malate on the activity of ciprofloxacin against Pseudomonas aeruginosa in different in vivo and in vivo -like infection models;Antimicrobial Agents and Chemotherapy;2023-11-15

5. Age of Antibiotic Resistance in MDR/XDR Clinical Pathogen of Pseudomonas aeruginosa;Pharmaceuticals;2023-08-30